Home >> Tag Archives: Roche Diagnostics— (page 2)

Tag Archives: Roche Diagnostics—

EGFR mutation liquid biopsy OK’d as companion Dx

June 2, 2016—The Food and Drug Administration has approved the Cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor gene mutations in non-small cell lung cancer patients, which are present in about 10 to 20 percent of such cancers. ...

Read More »